Leonardo Martin
@leonardomartin.bsky.social
Senior Researcher (PhysPhar • INFLA-MED) | Former AnatPath, ClinPath & Gen (Brazil • Germany • Poland) | Focus on regenerative medicine & gene/cell therapy #ATMPs | CVDs, MSDs, #cardioimmunology, #immunomodulation & #inflammation.
Proud to share our contribution with Prof. Gabbiani and Prof. De Meyer on #SMAD7 regulation in cardiac and skeletal tissue resolution, featured in @embomolmed.org (Vol. 17, No. 9 (Sep/ 2025) #CardioSky #fibrosis #muscle #vascular #inflammation
Read this Perspective by L Martin, G Gabbiani & GRY De Meyer at University of Antwerp on the role of #SMAD7 in cardiac, skeletal muscle, and vascular tissues.
🗞️ doi.org/10.1038/s443...
🗞️ doi.org/10.1038/s443...
October 21, 2025 at 6:00 PM
Proud to share our contribution with Prof. Gabbiani and Prof. De Meyer on #SMAD7 regulation in cardiac and skeletal tissue resolution, featured in @embomolmed.org (Vol. 17, No. 9 (Sep/ 2025) #CardioSky #fibrosis #muscle #vascular #inflammation
Check out our contribution to Vol. 22, Issue 10 (Oct-2025) of NRC!🫀 #CardioSky
New online! CD40–CD40L: a milestone in the recognition of atherosclerosis as an immune disease #CardioSky
CD40–CD40L: a milestone in the recognition of atherosclerosis as an immune disease
Nature Reviews Cardiology, Published online: 28 July 2025; doi:10.1038/s41569-025-01198-zLeonardo Martin and Guido De Meyer highlight the study that showed that blocking CD40–CD40L signalling could reduce atherosclerosis in mice in vivo.
bit.ly
October 21, 2025 at 5:50 PM
Check out our contribution to Vol. 22, Issue 10 (Oct-2025) of NRC!🫀 #CardioSky